3,5,9-Trioxa-4-phosphaheptacosan-1-aminium,4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R)-
| Title | Journal |
|---|---|
| Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. | Scientific reports 20180101 |
| Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species. | Lipids 20140601 |
| Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes. | International journal of pharmaceutics 20100330 |
| Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. | American journal of respiratory cell and molecular biology 20091201 |
| Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. | Journal of lipid research 20050401 |
| Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. | Biochemical and biophysical research communications 20050128 |
| Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. | Metabolism: clinical and experimental 20030301 |
| Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. | Blood 20020215 |
| How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus. | Virology 19970901 |